Literature DB >> 21179606

Antiviral agents in Alzheimer's disease: hope for the future?

Matthew A Wozniak1, Ruth F Itzhaki.   

Abstract

Entities:  

Year:  2010        PMID： 21179606      PMCID： PMC3002652          DOI： 10.1177/1756285610370069

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN： 1756-2856            Impact factor:   6.570


× No keyword cloud information.
  70 in total

1.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide.

Authors:  D H Cribbs; B Y Azizeh; C W Cotman; F M LaFerla
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

2.  Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains.

Authors:  G A Jamieson; N J Maitland; G K Wilcock; J Craske; R F Itzhaki
Journal:  J Med Virol       Date:  1991-04       Impact factor: 2.327

Review 3.  Immune dysregulation and chronic stress among older adults: a review.

Authors:  Jean-Philippe Gouin; Liisa Hantsoo; Janice K Kiecolt-Glaser
Journal:  Neuroimmunomodulation       Date:  2008-11-26       Impact factor: 2.492

4.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

5.  Herpes simplex encephalitis: involvement of apolipoprotein E genotype.

Authors:  W R Lin; M A Wozniak; M M Esiri; P Klenerman; R F Itzhaki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients.

Authors:  Matthew A Wozniak; Suzanne J Shipley; Marc Combrinck; Gordon K Wilcock; Ruth F Itzhaki
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

7.  Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes.

Authors:  Judith Miklossy; Andras Kis; Alexandra Radenovic; Lisa Miller; Laszlo Forro; Ralph Martins; Krzysztof Reiss; Nune Darbinian; Pushpa Darekar; Laszlo Mihaly; Kamel Khalili
Journal:  Neurobiol Aging       Date:  2006-02       Impact factor: 4.673

8.  Recurrent brainstem encephalitis associated with herpes simplex virus type 1 DNA in cerebrospinal fluid.

Authors:  K L Tyler; D G Tedder; L J Yamamoto; J A Klapper; R Ashley; K A Lichtenstein; M J Levin
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

9.  Stimulation of enveloped virus infection by beta-amyloid fibrils.

Authors:  Woj M Wojtowicz; Michael Farzan; John L Joyal; Kara Carter; Gregory J Babcock; David I Israel; Joseph Sodroski; Tajib Mirzabekov
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

10.  HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy.

Authors:  E H Corder; K Robertson; L Lannfelt; N Bogdanovic; G Eggertsen; J Wilkins; C Hall
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440
View more
  19 in total

Review 1.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

2.  Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.

Authors:  Walter J Lukiw; Jian Guo Cui; Li Yuan Yuan; Partha S Bhattacharjee; Madelyn Corkern; Christian Clement; Eli M Kammerman; M J Ball; Yuhai Zhao; Patrick M Sullivan; James M Hill
Journal:  Neuroreport       Date:  2010-10-06       Impact factor: 1.837

Review 3.  Autophagy interaction with herpes simplex virus type-1 infection.

Authors:  Douglas O'Connell; Chengyu Liang
Journal:  Autophagy       Date:  2016-03-02       Impact factor: 16.016

4.  Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.

Authors:  Nell S Lurain; Barbara A Hanson; Jeffrey Martinson; Sue E Leurgans; Alan L Landay; David A Bennett; Julie A Schneider
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

5.  Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.

Authors:  Matthew A Wozniak; Alison L Frost; Chris M Preston; Ruth F Itzhaki
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

6.  Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels.

Authors:  Catherine Féart; Catherine Helmer; Hervé Fleury; Yannick Béjot; Karen Ritchie; Philippe Amouyel; Susanna Schraen-Maschke; Luc Buée; Jean-Charles Lambert; Luc Letenneur; Jean-François Dartigues
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

Review 7.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

Review 8.  Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer's Disease (AD); Underwhelming Evidence against.

Authors:  Ruth F Itzhaki
Journal:  Vaccines (Basel)       Date:  2021-06-21

9.  Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study.

Authors:  Yang-Pei Chang; Guei-Fen Chiu; Fu-Chen Kuo; Chiou-Lian Lai; Yuan-Han Yang; Huang-Ming Hu; Pi-Yu Chang; Chiao-Yun Chen; Deng-Chyang Wu; Fang-Jung Yu
Journal:  Gastroenterol Res Pract       Date:  2013-11-25       Impact factor: 2.260

Review 10.  Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.

Authors:  Rodolfo Furlan Damiano; Bruno F Guedes; Cristiana Castanho de Rocca; Antonio de Pádua Serafim; Luiz Henrique Martins Castro; Carolina Demarchi Munhoz; Ricardo Nitrini; Geraldo Busatto Filho; Eurípedes Constantino Miguel; Giancarlo Lucchetti; Orestes Forlenza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-06-25       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.